Revolutionary AI platform that uses deep learning to predict molecular behavior and accelerate drug discovery. AtomNet neural networks analyze billions of molecular interactions to identify promising drug compounds in days rather than years. Has discovered potential treatments for Ebola, multiple sclerosis, and COVID-19. Partners with pharmaceutical companies and research institutions to reduce drug development timelines from 15 years to 3-5 years while cutting costs by 50%. Proven track record with multiple compounds entering clinical trials.
